Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(3 sites)
United States
Le Bonheur Childrens Hospital, Memphis, Tennessee Brazil
Hospital de Clinicas de Porto Alegre, Porto Alegre, Rio Grande do Sul Praxis Research Site, São Paulo